Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.505
-0.090 (-3.47%)
Jul 24, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 167.17 million as of July 24, 2026. Its market cap has decreased by -39.36% in one year.
Market Cap
167.17M
Enterprise Value
149.31M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.51
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 167.17M, an increase of 36.30%. That is a compound annual growth rate of 6.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 167.17M | -34.02% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 209.14M |
| IRLAB Therapeutics AB | 189.46M |
| Simris Group AB (PUBL) | 174.12M |
| Initiator Pharma | 166.34M |
| Xintela AB | 162.35M |
| Diamyd Medical AB | 159.63M |
| Alzinova AB | 151.98M |
| Biovica International AB | 143.04M |